Drug packaging: © Clariant.

Swiss speciality chemicals company Clariant is set to demonstrate the ‘future-proofing’ capabilities of its Mevopur and Remafin-EP products for pharmaceutical packaging and drug-delivery devices.

The demonstration will be carried out at the MD&M West exhibition ahead of the new US Pharmacopeia (USP) regulations.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Clariant North America medical and pharmaceutical manager Eric Rohr said that the company has already completed USP-compliance testing for pigment and additive ingredients in its Mevopur and Remafin-EP product ranges for pharmaceutical packaging applications.

“The Bormed service package, based on Borealis’ commitment, service and compliance to the healthcare industry, complements Clariant’s Mevopur promise for medical devices and packaging.”

With the completion of the tests, the company has opened new options for manufacturers who intend to change their drug packaging.

Clariant has also been selected as a distributor of Austria-based firm Borealis’ Bormed solutions of dedicated healthcare polyolefins.

Under the agreement, Clariant will be able to sell the complete Bormed portfolio of homopolymer and random copolymer polypropylene (PP), in addition to high-density polyethylene (HDPE) and Low-density polyethylene (LDPE) resins.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The company can also provide Bormed resins as ‘ready-to-use’ Mevopur compounds.

Bormed solutions are used for a wide range of medical devices, diagnostics and pharmaceutical packaging, including syringes, inhalers, intravenous (IV) bags dialysis filters, pipette tips, and packaging such as bottles and blow-fill seal (BFS) vials.

Rohr said: “The Bormed service package, based on Borealis’ commitment, service and compliance to the healthcare industry, complements Clariant’s Mevopur promise for medical devices and packaging.

“They are change-controlled, produced to consistently high standards, and tested for assured compliance with relevant European and US Pharmacopeia and ISO standards.”